What started as a small-scale fundraiser in the Kramer-Golinkoff’s living room has turned into so much more. With dozens of research grants funded; $52.3M in follow-on funding secured; a cystic fibrosis (CF) gene therapy company launched, acquired, and advancing two gene therapy candidates towards clinic; and a clinical trial matchmaking program developed to help speed clinical trial recruitment; Emily’s Entourage (EE) has come a long way since those early days!
From the lab to trials and through regulatory approvals, we are teeing up all steps of the drug development process so that the moment a therapy is ready, it reaches people with CF in record speed.
We believe that change starts with one person and one community that dreams of a better future and has the audacity to believe that that future is up to them. Join us on our mission to speed lifesaving breakthroughs and a cure for the final 10% of people with CF. Together, we can make a difference!
“We rejected the status quo, we defied the naysayers, we dreamt big, and ran with it … It goes to show that you don’t have to be a billionaire or a biologist or a big-time institution to make a real, measurable difference in the world.” – Emily Kramer-Golinkoff, co-founder, Emily’s Entourage
Our Mission
Fast Breakthroughs for Cystic Fibrosis
Emily’s Entourage accelerates research and drug development for the final 10% of people with cystic fibrosis (CF). By providing critical leadership and coordination, Emily’s Entourage drives high-impact research, cultivates multi-stakeholder collaboration, and facilitates information exchange to speed breakthroughs. Our goal is singular: to expedite lifesaving treatments and a cure for the final 10% who are waiting with bated and fading breath.